What does this research mean for the field?

Adeno-associated virus type 5 (AAV5) possesses a unique genome organization, distinct inverted terminal repeats, and a different cellular uptake mechanism compared to AAV2, leading to a lack of cross-complementation between the serotypes. Novelty: ClaimNovelty.NOVEL_FINDING. Consensus alignment: ConsensusAlignment.NEUTRAL.

What question did this study set out to answer?

To clone and sequence the genome of adeno-associated virus type 5 (AAV5) and evaluate its biological, structural, and transduction characteristics relative to other AAV serotypes.

February 1, 1999Journal of VirologyOpen Access

Cloning and Characterization of Adeno-Associated Virus Type 5

View Full Paper

Ask AI

Bookmark

Population

Adeno-associated virus type 5 (AAV5) genome, recombinant AAV5 particles, and various cell lines

Comparison

Cloning, sequencing, and characterization of the… vs AAV2 and other AAV serotypes

Design

Preclinical

Authors

JCJohn A. ChioriniNational Institutes of Health FKFrank KimCornell University LYLinda YangNorthwestern University

Discussion

Member takes

Implication

Requires serotype-specific vector evaluation in gene therapy; leaves open optimal AAV choice for clinical translation.

Key Points

To clone and sequence the genome of adeno-associated virus type 5 (AAV5) and evaluate its biological, structural, and transduction characteristics relative to other AAV serotypes.
Cloned and sequenced the full single-stranded DNA genome of AAV5, including its inverted terminal repeats (ITRs), rep, and cap open reading frames.
Engineered recombinant AAV5 particles to assess viral packaging and cross-complementation with AAV2 helper functions.
Measured transduction efficiency across multiple cell lines in the presence and absence of soluble heparin to analyze cellular uptake pathways.
The AAV5 rep gene exhibited 67% homology to AAV2, and the unique AAV5 ITRs lacked the consensus terminal resolution site, resulting in an absence of cross-complementation with AAV2.
Sequence alignment of the cap open reading frame identified divergent variable domains likely responsible for differences in particle stability and tissue tropism.
AAV5 displayed distinct cell transduction profiles relative to AAV2 and was not inhibited by soluble heparin, indicating a unique cellular entry mechanism.

Structured PICO

Population

Adeno-associated virus type 5 (AAV5) genome, recombinant AAV5 particles, and various cell lines

Intervention

Cloning, sequencing, and characterization of the AAV5 genome

Comparator

AAV2 and other AAV serotypes

Outcome

Genetic organization, homology to AAV2, ITR structure, cross-complementation, and transduction efficiency

AAV5 possesses distinct genetic and structural features compared to AAV2, resulting in a unique mechanism of cellular uptake and lack of cross-complementation.

Cite This Study

Chiorini et al. (1999) studied this question.

synapsesocial.com/papers/6a197975f2eb401dc78923b0 https://doi.org/10.1128/jvi.73.2.1309-1319.1999

View Full Paper

Ask AI

Bookmark

Cloning and Characterization of Adeno-Associated Virus Type 5

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Cloning and Characterization of Adeno-Associated Virus Type 5

Discussion

Member takes

Implication

Key Points

Structured PICO

Cite This Study

Also Consider

Also Consider